Gender and Age Characteristics of Mortality From Diseases of the Circulatory System of the Moscow region. Data 2016 year
https://doi.org/10.18087/cardio.2019.1.10215
Abstract
Contribution of diseases of the circulatory system to total mortality of the population remains high. Therefore it is necessary to study factors with most substantial impact on regional morbidity and mortality for elaboration of targeted programs of preventive measures aimed at definite population groups.
Purpose of this study was to perform analysis of differences of mortality from cardiovascular diseases (VVD) of Moscow region inhabitants of various gender and age.
Materials and methods. Data on 2016 mortality of Federal Service of State Statistics (Rosstat) and territorial service of state statistics of the Moscow Region were used in this analysis. Analysis was conducted for men and women divided in age groups ≤50, 50–59, 60–69, and ≥50 years. Diseases were classified in accordance with 10th Revision of International Statistical Classification of Diseases (ICD10).
Results. Population of the Moscow Region territory on January 1, 2016, amounted 7 318 647 (men 46.2, women 53.8 %, persons of working age 58.9 %). Contribution in the mortality structure of chronic ischemic heart disease (IHD) and cerebro-vascular diseases in women was greater than in men (80 vs. 68 %, respectively, р<0.0001). Contribution of acute IHD, IHD unrelated heart diseases, and vascular diseases in men was significantly greater than in women (30 vs. 18 %, respectively, р<0.0001). In the age group over working age mortality indexes were substantially higher compared with those in working age. In men these indexes became 10–20 times while in women – 30–130 times higher.
Conclusion. Despite positive dynamics of mortality from diseases of the circulatory system (45.3 % lowering from 2008 to 2016) it is necessary to strengthen efforts directed to correction risk factors of IHD and implementation of timely diagnostics and correction of IHD unrelated diseases.
About the Author
M. G. Glezer
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Glezer Mariya G. – MD, professor
Moscow
References
1. Heart disease and stroke statistics — 2015 update: a report from the American Heart Association. Mozaffarian D., Benjamin E.J., Go A.S. et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2015;131(4):e29–322. DOI: 10.1161/CIR.0000000000000152.
2. Timmis A., Townsend N., Gale C. et al.; Atlas Writing Group. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J 2017 Nov 27. DOI: 10.1093/eurheartj/ehx628
3. www.gks.ru
4. www.msko.gks.ru
5. Mortality trends in Canada, 2013. Report on the Demographic Situation in Canada Mortality: Overview, 2012 and 2013. www.statcan.gc.ca.
6. Nichols M., Townsend N., Scarborough P., Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J 2013 Oct;34(39):3017–27. DOI: 10.1093/eurheartj/eht159.
7. Chazova I.E., Oschepkova E.V. Improving medical care to patients with cardiovascular diseases. Vestnik Roszdravnadzora 2015;5:7–11. Russian (Чазова И.Е., Ощепкова Е.В. Борьба с сердечно-сосудистыми заболеваниями: проблемы и пути их решения на современном этапе. Вестник Росздравнадзора 2015;5:7–11.)
8. Oshchepkova E.V., Efremova Iu.E., Karpov Iu.A. Myocardial infarction morbidity and mortality in the Russian Federation in 2000–2011. Terapevticheskii arkhiv 2013;85(4):4–10. Russian (Ощепкова Е.В., Ефремова Ю.Е., Карпов Ю.А. Заболеваемость и смертность от инфаркта миокарда в Российской Федерации в 2000–2011 гг. Терапевтический архив 2013;85(4):4–10.)
9. Boytsov S.A., Samorodskaya I.V., Nikulina N.N. et al. Comparative analysis of mortality from acute forms of ischemic heart disease during a 15-year period in the Russian Federation and the United States and the factors influencing its formation Terapevticheskii arkhiv 2017;89(9):53–59. DOI:10.17116/terarkh201789953-59. Russian (Бойцов С.А., Самородская И.В., Никулина Н.Н. и др. Сравнительный анализ смертности населения от острых форм ишемической болезни сердца за пятнадцатилетний период в РФ и США и факторов, влияющих на ее формирование. Терапевтический архив 2017;89(9):53–59.) DOI: 10.17116/terarkh201789953–59
10. Boytsov S.A., Nikulina N.N., Yakushin S.S. et al. Acute ischaemic heart disease in elderly and senile: analysis of morbidity, morta lity and detectability results of Russian multicentral epidemiological study of morbidity, mortality, diagnostics and treatment quality of ischaemic heart disease acute forms (RESONANCE). Clinical Gerontology 2011;1:73–78. Russian (Бойцов С.А., Никулина Н.Н., Якушин С.С. и др. Острые формы ишемической болезни сердца в пожилом и старческом возрасте: анализ заболеваемости, летальности и диагностики по результатам Российского многоцентрового эпидемиологического исследования заболеваемости, смертности, качества диагностики и лечения острых форм ИБС (РЕЗОНАНС). Клиническая геронтология 2011;1:73–78.)
11. Tolpygina S.N., Polyanskaya Yu.N., Martsevich S.Yu. Treatment of patients with chronic ischemic heart disease in real clinical practice according to the data from PROGNOZ IBS register (Part 1). Ration Pharmacother Cardiol 2013;9(2):138–142. Russian (Толпыгина С.Н., Полянская Ю.Н., Марцевич С.Ю. Лечение пациентов с хронической ишемической болезнью сердца в реальной клинической практике по данным регистра «ПРОГНОЗ ИБС» (Часть 1). Рациональная фармакотерапия в кардиологии 2013;9(2):138–142.)
12. Glezer M.G. LINKOR: results of observational program in patients with myocardial infarction. Kardiologiya 2013;53(5):74–82. Russian (Глезер М.Г. от лица участников программы Линкор: результаты наблюдательной программы пациентов, перенесших инфаркт миокарда. Кардиология 2013;53(5):74–82.)
13. Spence J.D. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention. Can J Cardiol 2017;33(5):626– 634. DOI: 10.1016/j.cjca.2017.01.003.
14. Nikolic D., Banach M., Nikfar S. et al.; Lipid and Blood Pressure Meta-Analysis Collaboration Group. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 2013;168(6):5437–5447. DOI:10.1016/j.ijcard.2013.08.060.
15. Lipid Modification. Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease NICE Clinical Guidelines, No. 181 London: National Institute for Health and Care Excellence (UK); 2014 Jul.
16. Sudlow C.L., Warlow C.P. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997;28(3):491–499.
17. Meschia J.F., Bushnell C., Boden-Albala B. et al.; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014;45(12):3754–3832. DOI: 10.1161/STR.0000000000000046.
18. Ogunmoroti O., Oni E., Michos E.D. et al. Life’s Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2017;6(6). pii: e005180. DOI: 10.1161/JAHA.116.005180.
19. O’Donnell M.J., Xavier D., Liu L. et al.; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–123. DOI: 10.1016/S0140-6736(10)60834-3.
20. Akesson A., Larsson S.C., Discacciati A., Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J Am Coll Cardiol 2014;64(13):1299–1306. DOI: 10.1016/j.jacc.2014.06.1190.
21. Glezer M.G., Deev A.D. How to Increase the Effectiveness of Antihypertensive Therapy in Clinical Practice: Results of the Russian Observational Program FORSAZH. Kardiologiya 2016;56(1):18–24. DOI: 10.18565/cardio.2016.1.13-24. Russian (Глезер М.Г., Деев А.Д. от имени участников программы ФОРСАЖ. Как увеличить эффективность антигипертензивной терапии в реальной клинической практике: результаты российской наблюдательной программы ФОРСАЖ. Кардиология 2016;56(1):18–24.) DOI: 10.18565/cardio.2016.1.13-24
22. Glezer M.G. on behalf of program participants The Use of Fixed Perindopril A/Amlodipine Combination Provides High Compliance to Therapy, Effective and Safe Arterial Pressure Lowering in Patients With Previous Inefferctive Therapy. The POTENTIAL Program Kardioogiia 2015;(55):(12):17– 24. DOI: https://dx.doi.org/10.18565/cardio.2015.12.17–24. Russian (Глезер М. Г. от лица участников программы Программа ПОТЕНЦИАЛ: использование фиксированной комбинации периндоприла А/амлодипина обеспечивает высокую приверженность к терапии эффективное и безопасное снижение артериального давления у пациентов с ранее неэффективной комбинированной терапией. Кардиология 2015;55(12):17–24.) DOI: https://dx.doi.org/10.18565/cardio.2015.12.17–24).
23. Rapsomaniki E., Timmis A., George J. et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet 2014;383(9932):1899–1911. DOI: 10.1016/S0140-6736(14)60685-1.
24. Glezer M. G., Saigitov R. T. on behalf of the Athena study participants Effective Treatment of Arterial Hypertension in Women Reduces Frequency of Calls for Medical Aid Because of Urgent Indications. Kardiologiya 2009;6:19–26. Russian (Глезер М. Г., Сайгитов Р. Т. Эффективное лечение артериальной гипертонии у женщин снижает шансы обращения за медицинской помощью по экстренным показаниям. Результаты исследования АФИНА. Кардиология 2009;6:19–26.)
25. Mareev V. Yu., Fomin I. V., Ageev F. T. et al. Clinical guidelines. chronic heart failure (CHF). Russian Heart Failure J. 2017;18(1):3–40 DOI: 10.18087/rhfj.2017.1.2346. (Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная Недостаточность. 2017;18(1):3–40 DOI: 10.18087/rhfj.2017.1.2346)
26. Ivanova A.E., Golovenkin S.E., Mikhailov A.Yu. Evaluation of the effectiveness of policies to reduce mortality from cardiovascular diseases Social aspects of public health 2014;37(3):1. Russian (Иванова А.Е., Головенкин С.Е., Михайлов А.Ю. Оценка результативности мер политики по снижению смертности от сердечно-сосудистых заболеваний. Социальные аспекты здоровья населения 2014;37(3):1.)
Review
For citations:
Glezer M.G. Gender and Age Characteristics of Mortality From Diseases of the Circulatory System of the Moscow region. Data 2016 year. Kardiologiia. 2019;59(1):49-56. (In Russ.) https://doi.org/10.18087/cardio.2019.1.10215
Views:
4245
Email this article 
Post a Comment 
